Contact an Attorney
| NSF and MRI Contrast Agents |
 The FDA has requested that the makers of gadolinium-based contrast agents place a new risk warning on thier products. The warning pertains to the risk of a rare...
but life threatening skin disease associated with the agents. Kidney and liver patients are particularlly at risk for developing Nephrogenic Systemic Fibrosis (NSF), also known as Nephrogenic Fibrosing Dermopathy (NDF). The new warning would apply to five gadolinium-based agents that have been approved for use in the U.S.
If you have recently had a MRI and have kindney problems you could be at risk. If you or someone you love has been affected by gadolinium we can help. |
